Milestone Pharmaceuticals Inc. - Common Stock (MIST)

Historical Holders from Q2 2019 to Q3 2025

Symbol
MIST on Nasdaq
Type / Class
Equity / Common Stock
Shares outstanding
89.5M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
34.1M
Holdings value
$68.3M
% of all portfolios
0.003%
Grand Portfolio weight change
+0%
Number of holders
61
Number of buys
44
Number of sells
-11
Average Value change %
+0%
Average buys %
+0.001%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Milestone Pharmaceuticals Inc. - Common Stock (MIST)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
RTW INVESTMENTS, LP 9.9% -0.9% $18.3M $7.03M 9.16M +62.3% RTW Investments, LP 30 Sep 2025
Trails Edge Capital Partners, LP 9.9% 0% $18M $340K 9.02M +1.92% Trails Edge Capital Partners, LP 30 Sep 2025
Propel Bio Management, LLC 9.9% $21M 8.86M Propel Bio Management, LLC 11 Jul 2025
Adage Capital Management, L.P. 9.99% $17.3M 8.66M Adage Capital Management, L.P. 30 Sep 2025
INTEGRATED CORE STRATEGIES (US) LLC 0.6% $396K 322K Integrated Core Strategies (US) LLC 31 Mar 2025

Institutional Holders of Milestone Pharmaceuticals Inc. - Common Stock (MIST)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 34.1M $68.3M +$44.8M $2.00 61
2025 Q2 11.8M $22.9M +$893K $1.94 43
2025 Q1 11.8M $9.46M -$26M $0.80 43
2024 Q4 24.6M $57.9M -$9.78M $2.36 46
2024 Q3 28.7M $43.6M -$2.29M $1.52 41
2024 Q2 30.2M $39.9M -$1.77M $1.32 39
2024 Q1 31.1M $55.6M +$23.9M $1.79 40
2023 Q4 17.8M $29.7M -$3.79M $1.67 40
2023 Q3 19.6M $60.7M -$3.31M $3.10 39
2023 Q2 20.7M $59M -$3.14M $2.85 48
2023 Q1 21.7M $85.5M -$9.71M $3.94 49
2022 Q4 23.7M $94M -$28.9M $3.96 55
2022 Q3 20.4M $187M +$10.1M $9.19 43
2022 Q2 20.8M $127M -$2.81M $6.15 29
2022 Q1 21M $135M +$5.03M $6.42 28
2021 Q4 20.2M $133M +$1.82M $6.55 27
2021 Q3 20M $114M -$1.09M $5.71 26
2021 Q2 20.1M $111M -$885K $5.50 26
2021 Q1 20.3M $117M -$2M $5.79 31
2020 Q4 20.6M $138M +$34M $6.70 33
2020 Q3 15.5M $113M +$42.8M $7.32 29
2020 Q2 9.75M $36.9M +$2.94M $3.78 23
2020 Q1 9.24M $17M -$32.7M $1.84 16
2019 Q4 14.4M $231M +$20.6M $16.01 25
2019 Q3 13.1M $240M -$2.84M $18.65 23
2019 Q2 13.1M $350M +$350M $27.15 25